Merck, referred to as MSD outside the US and Canada, has obtained FDA approval for Liptruzet tablets as an adjunctive therapy to diet for the treatment of elevated low-density lipoprotein (LDL) cholesterol in primary or mixed hyperlipidemia ...
Tags: Merck, Liptruzet Tablets